CFA
ANAC

Carroll Financial Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Carroll Financial Associates’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16
Closed – – 1313
2016
Q1 		$0 Buy
+16
New +$1.18K ﹤0.01% 1317

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Carroll Financial Associates's ANAC Position: Q2 2016 in Review

Carroll Financial Associates sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 16 shares.

Carroll Financial Associates first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Carroll Financial Associates reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Carroll Financial Associates sold 16 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016.
  • Carroll Financial Associates first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
  • Carroll Financial Associates's ANACOR PHARMACEUTICALS INC COM position peaked at $0 in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Carroll Financial Associates's 13F filing for Q2 2016, filed 18 Jul 2016.